Joshua Higa
Vice President of Investor Relations
Replay available
Ultragenyx Pharmaceutical Inc. (RARE) Q2 2025 Earnings Call
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) Q2 2025 earnings conference call, held 2025-08-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Emil Kakas
Chief Executive Officer and President
Eric Harris
Chief Commercial Officer
Howard Horn
Chief Financial Officer
Eric Krambes
Chief Medical Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ultragenyx Pharmaceutical Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.495 Good afternoon and welcome to the Ultragenix second quarter 2025 financial results conference 00:00:04.495 -- 00:00:08.499 call. At this time, all participants are in a listen-only mode. 00:00:08.499 -- 00:00:12.362 At the end of the prepared remarks, you will have an opportunity to ask questions during 00:00:12.362 -- 00:00:17.827 the Q&A portion of the call. It is now my pleasure to turn the call to Joshua Higa, 00:00:17.827 -- 00:00:20.989 Vice President of Investor Relations. 00:00:21.411 -- 00:00:25.354 Thank you. We have issued a press release detailing our financial results, which you 00:00:25.354 -- 00:00:28.533 can find on our website at ultragenix.com. 00:00:28.533 -- 00:00:33.659 Joining me on this call are Emil Kakas, Chief Executive Officer and President, Eric Harris, 00:00:33.659 -- 00:00:39.005 Chief Commercial Officer, Howard Horn, Chief Financial Officer, and Eric Krambes, 00:00:39.005 -- 00:00:43.309 Chief Medical Officer. I'd like to remind everyone that during today's call, we will 00:00:43.309 -- 00:00:47.434 be making forward-looking statements. These statements are subject to certain risks and 00:00:47.434 -- 00:00:51.338 uncertainties, and our actual results may differ materially. 00:00:51.338 -- 00:00:55.123 Please refer to the risk factors discussed in our latest SEC filings. 00:00:55.123 -- 00:00:57.811 And now I'll turn the call over to Emil. 00:00:57.811 -- 00:01:00.635 Thanks, Josh, and good afternoon, everyone. 00:01:00.635 -- 00:01:05.182 In April 2025, we marked our 15-year anniversary as a company. 00:01:05.182 -- 00:01:09.008 Over that time, we've taken four programs all the way through approval in multiple regions 00:01:09.008 -- 00:01:13.656 and added a fifth that we are commercializing outside ...